AzTrials
AzTrials

Facial PalsyNCT07325604

Effect of Neuromuscular Electrical Stimulation on Unilateral Central Facial Palsy

A study testing Neuromuscular electrical stimulation (NMES) in people with Facial Palsy and Stroke, run by University of Aarhus at 1 site in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Background Central facial palsy (CFP) is a common condition in stroke, with an estimated prevalence of 45%. CFP can lead to facial asymmetry, problems with mouth closure and food processing, bite marks on the cheek, social isolation, and reduced quality of life. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Facial Palsy, Stroke
What is being tested?
Neuromuscular electrical stimulation (NMES)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 siteDenmark
Study dates
27 Feb 2026to 15 Dec 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Central facial palsy
  • First time stroke
  • >=18 years
  • Able to provide written consent

Who cannot join

  • Not able to cooperate for mimical exercises
  • Contraindications for NMES
  • Admitted for three weeks assessment stay at the hospital

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Jesper Fabricius, PhD contact

+4578419051

jesperjm@hotmail.com

Denmark1 site, 1 recruiting
  • Hammel neurorehabilitation centre and university research clinic

    Hammel, 8450

    Jesper Fabricius, PhD, +4578419051, jesperjm@hotmail.com

    jesperjm@hotmail.com

    Recruiting

Other trials in Denmark

About this study

Official title: Effect of Neuromuscular Electrical Stimulation on Unilaterial Central Facial Palsy: An Assesorblinded Randomized Controlled Trial

Background Central facial palsy (CFP) is a common condition in stroke, with an estimated prevalence of 45%. CFP can lead to facial asymmetry, problems with mouth closure and food processing, bite marks on the cheek, social isolation, and reduced quality of life. CFP is seen as an important area of rehabilitation, and training is therefore often carried out to reduce the consequences of CFP. In a recent systematic review conducted by the principal investigator, the results showed that very few studies have been conducted that have investigated the effect of training for CFP, and there is currently no scientific evidence to support the effect of the various training interventions.

Objective To investigate the effect of Neuromuscular electrical stimulation (NMES) on facial symmetry compared to usual practice, in participants with CFP as a result of stroke.

Read more

Hypothesis: Participants who receive training with NMES together with usual training for facial paralysis have greater improvement in facial symmetry than participants who only receive usual training for facial paralysis.

Trial design Randomized controlled trial (RCT) with a nested pilot trial. A pilot trial/RCT will be conducted in order to power calculation in an RCT. The protocol for the pilot trial and RCT will be the same, and participants from the pilot trial and their outcome data are thus expected to be included in the RCT.

Conditions
Facial Palsy, Stroke
Being tested
Neuromuscular electrical stimulation (NMES), Usual Care
Keywords
NMES, Central facial palsy, Multicenter RCT, Stroke, Facial symmetry
Medical subject headings
Facial Paralysis, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neuromuscular electrical stimulation (NMES)Device

    Electrical stimulation of facial muscles.

  • Usual CareOther

    This arm receives usual care of facial palsy without NMES. Usual care encompass mimical exercises, facio oral sensory input, and kinesio taping.

Study groups in NCT07325604
Study groupRoleWhat they receive
NMESExperimentalNMES is provided as an add-on to usual care
Receives: Device: Neuromuscular electrical stimulation (NMES); Other: Usual Care
Usual careActive comparatorThis arm receives usual care of facial palsy without NMES. Usual care encompass mimical exercises, facio oral sensory input, and kinesio taping.
Receives: Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. My Facial Quantification (MyFacialQ)

    MyFacialQ quantifies degree of unilateral facial palsy through video recordings of mimical exercises. The development and validation study for MyFacialQ is in review.

    Measured: From enrollment to the end of treatment at four weeks"

Secondary outcomes (2)
  1. Iowa Oral Performance Instrument (IOPI)

    Measurement of lip strength

    Measured: From enrollment to the end of treatment at four weeks

  2. Facial Clinimetric Evaluation (FACE)

    Patient reported outcome on facial palsy

    Measured: From enrollment to three months follow-up after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2026
  2. Study start27 Feb 2026
  3. Primary completion15 Dec 2030 (estimated)
  4. Study completion15 Dec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
130 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07325604
Sponsor's protocol ID
955087
Other IDs
2501205
Status last verified
Jan 2026
First submitted
7 Jan 2026
Last updated
9 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: IPD raw data is mainly video recordings, and these will not be shared. However aggregated measures from the video recordings may be shared.

Questions about this trial

What is this clinical trial studying?

A study testing Neuromuscular electrical stimulation (NMES) in people with Facial Palsy and Stroke, run by University of Aarhus at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jesper Fabricius, PhD (+4578419051, jesperjm@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

My Facial Quantification (MyFacialQ) (time frame: From enrollment to the end of treatment at four weeks"). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in